860628P

C24 Dihydroceramide (d18:0/24:0)

Avanti Research^™ - A Croda Brand 860628P, powder

• Synonym(e): N-lignoceroyl-D-erythro-sphinganine
• Empirische Formel (Hill-System): C₄₂H₈₅NO₃
• CAS-Nummer: 6063-36-1
• Molekulargewicht: 652.13
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: powder
• Verpackung: pkg of 1 × 10 mg (860628P-10mg); pkg of 1 × 25 mg (860628P-25mg); pkg of 1 × 5 mg (860628P-5mg); pkg of 1 × 50 mg (860628P-50mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 860628P
• Lipid-Typ: sphingolipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: OC[C@]([H])(NC(CCCCCCCCCCCCCCCCCCCCCCC)=O)[C@]([H])(O)CCCCCCCCCCCCCCC
• InChI: 1S/C42H85NO3/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-42(46)43-40(39-44)41(45)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2/h40-41,44-45H,3-39H2,1-2H3,(H,43,46)/t40-,41+/m0/s1
• InChIKey: BPLYVSYSBPLDOA-WVILEFPPSA-N

Beschreibung

Biochem./physiol. Wirkung

Dihydroceramide acts as a precursor for ceramide synthesis. It has an ability to induce autophagy in the perinuclear region. Dihydroceramide affects autophagic flux and enhances the formation of lipid droplets.

Verpackung

5 mL Amber Glass Screw Cap Vial (860628P-10mg)

5 mL Amber Glass Screw Cap Vial (860628P-25mg)

5 mL Amber Glass Screw Cap Vial (860628P-50mg)

5 mL Amber Glass Screw Cap Vial (860628P-5mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids